DK170513B1 - Topiske præparater omfattende melatoninforbindelser samt anvendelsen af disse - Google Patents

Topiske præparater omfattende melatoninforbindelser samt anvendelsen af disse Download PDF

Info

Publication number
DK170513B1
DK170513B1 DK522186A DK522186A DK170513B1 DK 170513 B1 DK170513 B1 DK 170513B1 DK 522186 A DK522186 A DK 522186A DK 522186 A DK522186 A DK 522186A DK 170513 B1 DK170513 B1 DK 170513B1
Authority
DK
Denmark
Prior art keywords
melatonin
composition
active compound
skin
preparation
Prior art date
Application number
DK522186A
Other languages
Danish (da)
English (en)
Other versions
DK522186D0 (da
DK522186A (da
Inventor
Walter Pierpaoli
William Regelson
Original Assignee
Cell Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858505537A external-priority patent/GB8505537D0/en
Priority claimed from US06/770,054 external-priority patent/US4746674A/en
Application filed by Cell Eng Ag filed Critical Cell Eng Ag
Publication of DK522186D0 publication Critical patent/DK522186D0/da
Publication of DK522186A publication Critical patent/DK522186A/da
Application granted granted Critical
Publication of DK170513B1 publication Critical patent/DK170513B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK522186A 1985-03-04 1986-10-31 Topiske præparater omfattende melatoninforbindelser samt anvendelsen af disse DK170513B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858505537A GB8505537D0 (en) 1985-03-04 1985-03-04 Compositions containing melatonin/homologues
GB8505537 1985-03-04
US77005485 1985-08-27
US06/770,054 US4746674A (en) 1985-08-27 1985-08-27 Melatonin compositions and uses thereof
PCT/EP1986/000108 WO1986005093A2 (fr) 1985-03-04 1986-03-03 Compositions de melatonine et leurs utilisations
EP8600108 1986-03-03

Publications (3)

Publication Number Publication Date
DK522186D0 DK522186D0 (da) 1986-10-31
DK522186A DK522186A (da) 1986-10-31
DK170513B1 true DK170513B1 (da) 1995-10-09

Family

ID=26288902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK522186A DK170513B1 (da) 1985-03-04 1986-10-31 Topiske præparater omfattende melatoninforbindelser samt anvendelsen af disse

Country Status (7)

Country Link
EP (1) EP0214254B1 (fr)
JP (1) JPH0778007B2 (fr)
AT (1) ATE77230T1 (fr)
AU (1) AU5626786A (fr)
DE (1) DE3685696T2 (fr)
DK (1) DK170513B1 (fr)
WO (1) WO1986005093A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
GB8727099D0 (en) * 1987-11-19 1987-12-23 Cellena Cell Eng A G Compositions containing melantonin/homologues
JPH03145419A (ja) * 1989-10-31 1991-06-20 Shiseido Co Ltd 紫外線老化の防御薬剤
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
FR2741802B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine pour traiter les peaux sensibles
ES2101660B1 (es) * 1995-12-21 1997-12-16 Soler Armando Jose Yanez Nuevo crecepelo de uso topico.
FR2751539B1 (fr) * 1996-07-25 1998-12-04 Oreal Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
FR2751536B1 (fr) * 1996-07-25 1998-11-06 Oreal Nouveaux derives de le melatonine anti-radicaux libres et compositions les comprenant
FR2751535B1 (fr) † 1996-07-25 1998-11-27 Oreal Utilisation de derives de la melatonine pour la la depigmentation de la peau et compositions les comprenant
FR2754454B1 (fr) * 1996-10-10 1998-11-27 Oreal Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues
FR2756733B1 (fr) * 1996-12-06 1999-01-08 Oreal Utilisation de la melatonine ou ses analogues pour inhiber la pigmentation de la peau humaine induite par l'alpha-msh
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
ITGE20070009A1 (it) * 2007-01-24 2008-07-25 Leila Baeram Composizione cosmetica e metodo per favorire la ricrescita dei capelli.
IT1406864B1 (it) * 2011-01-10 2014-03-14 Endrici Composizione per il trattamento dell'acne
DE102019131415A1 (de) * 2019-11-21 2021-05-27 Lukas Karrer Kosmetische Pflege von ergrautem Haar und Wiederrückführung von ergrautem Haar zur ursprünglichen Haarfarbe
CN111034616B (zh) * 2019-12-25 2022-05-06 甘肃农业大学 西兰花毛状根高萝卜硫苷和萝卜硫素合成释放培养方法

Also Published As

Publication number Publication date
DK522186D0 (da) 1986-10-31
AU5626786A (en) 1986-09-24
JPH0778007B2 (ja) 1995-08-23
DE3685696T2 (de) 1993-01-14
WO1986005093A2 (fr) 1986-09-12
EP0214254A1 (fr) 1987-03-18
DK522186A (da) 1986-10-31
DE3685696D1 (de) 1992-07-23
ATE77230T1 (de) 1992-07-15
JPS62502118A (ja) 1987-08-20
EP0214254B1 (fr) 1992-06-17

Similar Documents

Publication Publication Date Title
US4746674A (en) Melatonin compositions and uses thereof
DK170513B1 (da) Topiske præparater omfattende melatoninforbindelser samt anvendelsen af disse
Diani et al. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque
Martini The 5α-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications
US8025893B2 (en) Use of a specific inhibitor of hedgehog/smoothened signaling on hyperpigmented skin to obtain decrease of pigmentation
Stenn et al. Glucocorticoid effect on hair growth initiation: a reconsideration
AU2008323198B2 (en) C-19 steroids for cosmetic and further uses
WO1987000432A2 (fr) Compositions contenant de la melatonine ou ses homologues, leurs utilisations pour le traitement du psoriasis vulgaris et/ou des affections apparentees
Lamberts et al. Studies on the mechanism of the GABA-mediated inhibition of prolactin secretion
KR20200014295A (ko) 트리파타이트(tripartite) 안드로겐 수용체 제거제, 그 방법 및 용도
EP0565296B1 (fr) Utilisation de mélatine pour la fabrication d'un médicament pour le traitement de l'hyperplasie bénine de la prostate
Pomerantz et al. Serotonergic influences on male sexual behavior of rhesus monkeys: effects of serotonin agonists
Aguilar et al. Testicular serotonin is related to mast cells but not to Leydig cells in the rat
Bergstrom et al. Melatonin: the dark force
CZ300126B6 (cs) Indolové deriváty
CA1292947C (fr) Composes de melatonine et leurs utilisations
Brzezinski “Melatonin replacement therapy” for postmenopausal women: is it justified?
Foy et al. Estrogen and hippocampal synaptic plasticity
Sourla et al. Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin
Somade et al. Effect of edible camphor administrations on levels of steroid and thyroid hormones in male wistar rats
Chu et al. Stimulatory and entraining effect of melatonin on tuberoinfundibular dopaminergic neuron activity and inhibition on prolactin secretion
Wise Aging of the female reproductive system: a neuroendocrine perspective
Haji et al. Excess in vitro prolactin secretion by pituitary cells from ovariectomized old rats
Lubicz-Nawrocki et al. The comparative efficacy of testosterone, progesterone, and dehydroepiandrosterone for the maintenance of fertilizing capacity in castrated hamsters
Kaplanski et al. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK